Aspirin for primary prevention of atherosclerotic cardiovascular events
- PMID: 32357985
- DOI: 10.3949/ccjm.87a.19045
Aspirin for primary prevention of atherosclerotic cardiovascular events
Abstract
Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.
Comment in
-
Aspirin for primary prevention.Cleve Clin J Med. 2020 Jul 31;87(8):458. doi: 10.3949/ccjm.87c.08005. Cleve Clin J Med. 2020. PMID: 32737041 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical